rs750636662
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM1PP5
The NM_152443.3(RDH12):c.701G>A(p.Arg234His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000416 in 1,610,986 control chromosomes in the GnomAD database, with no homozygous occurrence. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R234C) has been classified as Uncertain significance.
Frequency
Consequence
NM_152443.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RDH12 | NM_152443.3 | c.701G>A | p.Arg234His | missense_variant | 8/9 | ENST00000551171.6 | |
RDH12 | XM_047430965.1 | c.701G>A | p.Arg234His | missense_variant | 8/9 | ||
ZFYVE26 | XM_047431173.1 | c.*509C>T | 3_prime_UTR_variant | 42/42 | |||
GPHN | XM_047430879.1 | c.1313-5962G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RDH12 | ENST00000551171.6 | c.701G>A | p.Arg234His | missense_variant | 8/9 | 1 | NM_152443.3 | P1 | |
RDH12 | ENST00000267502.3 | c.701G>A | p.Arg234His | missense_variant | 7/8 | 5 | P1 | ||
ZFYVE26 | ENST00000394455.6 | n.3266C>T | non_coding_transcript_exon_variant | 14/15 | 2 | ||||
RDH12 | ENST00000552873.1 | n.70G>A | non_coding_transcript_exon_variant | 2/2 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152168Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000925 AC: 23AN: 248732Hom.: 0 AF XY: 0.0000964 AC XY: 13AN XY: 134806
GnomAD4 exome AF: 0.0000370 AC: 54AN: 1458818Hom.: 0 Cov.: 31 AF XY: 0.0000413 AC XY: 30AN XY: 725792
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152168Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74328
ClinVar
Submissions by phenotype
Leber congenital amaurosis 13 Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Dec 18, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 234 of the RDH12 protein (p.Arg234His). This variant is present in population databases (rs750636662, gnomAD 0.06%). This missense change has been observed in individual(s) with autosomal recessive macular or retinal dystrophy (PMID: 19011012, 30979730; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 313842). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RDH12 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects RDH12 function (PMID: 16269441). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 14, 2024 | - - |
Leber congenital amaurosis Pathogenic:1Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Jan 30, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 09, 2022 | Variant summary: RDH12 c.701G>A (p.Arg234His) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 9.2e-05 in 248732 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in RDH12 causing Leber Congenital Amaurosis (9.2e-05 vs 0.0016), allowing no conclusion about variant significance. c.701G>A has been reported in the literature as biallelic compound heterozygous genotypes in multiple individuals affected with features of RDH12-related retinal dystrophy (example, Thompson_2005, Valverde_2009, Mendez-Vidal_2014, Glockle_2014, Avila-Fernandez_2010, Martin-Merida_2019, Ba-Abbad_2020, De Zaeytijd_2021). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 44% of normal retinoid reductase activity (Thompson_2005). A threshold effect resulting from co-inheritance with another loss of function (LOF) variant, combined with a reduction in p.R234H activity to less than half of wild-type, resulting in insufficient RDH12 enzyme levels for normal visual cycle function has been proposed (Thompson_2005). Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments (P/LP, n=3; VUS, n=3). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Macular dystrophy Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Ocular Genomics Institute, Massachusetts Eye and Ear | Aug 01, 2019 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 04, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; In vitro functional studies demonstrated that R234H retained 44% enzyme activity level compared to wild type (Thompson et al., 2005); Observed with a missense variant on the opposite allele (in trans) in individuals with retinal dystrophy in published literature (Thompson et al., 2005; Avila-Fernandez et al., 2010; Consugar et al., 2015); This variant is associated with the following publications: (PMID: 25412400, 16269441, 19011012, 21151602, 25494902, 32790509) - |
Retinal dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Ophthalmic Genetics Group, Institute of Molecular and Clinical Ophthalmology Basel | Jul 24, 2023 | Clinical significance based on ACMG v2.0 - |
Retinitis pigmentosa Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | The RDH12 c.701G>A (p.Arg234His) missense variant has been identified in at least four studies in which it is found in at least four patients, including at least two individuals with an autosomal recessive form of retinitis pigmentosa (RP) and one individual with macular dystrophy, all three of whom carried the variant in a compound heterozygous state. A fourth individual with RP carried the p.Arg234His variant in a heterozygous state along with a homozygous missense variant in another gene associated with RP, so the contribution of the p.Arg234His variant to disease in this patient is unclear ((Thompson et al. 2005; Ãvila-Fernández et al. 2010; Consugar et al. 2014; Méndez-Vidal et al. 2014). Control data are unavailable for the p.Arg234His variant, which is reported at a frequency of 0.00095 in the Latino population of the Exome Aggregation Consortium. Functional analysis in COS-7 cells demonstrated that in the presence of some substrates, protein activity was 44% in cells transfected with the p.Arg234His variant compared to wild type, although notably the p.Arg234His demonstrated a higher activity level than the other variants assessed (Thompson et al. 2005). Further, the variant protein was expressed at levels similar to wild type when assayed by Western blotting and immunohistochemistry, leading the authors to suggest the variant may not be disease-causing. Based on the evidence, the p.Arg234His variant is classified as a variant of unknown significance, but suspicious for pathogenicity for retinitis pigmentosa. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at